PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:06 AM ET

Sponsor Check › Management entity

BR

BIOS Research

Management entity named on Form D filings · TX · Aug 12, 2015 → Mar 24, 2017

5deals (issuers)
$25.4Mreported sold
189investors
5Form D filings
2015–2017years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:15 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

BIOS Research is a management entity listed as a promoter on 5 SEC Form D filings by 5 issuers between Aug 2015 and Mar 2017: BIOS Fund I, LP (Fort Worth, TX — pooled investment fund — 2017; $14.4M reported sold to 87 investors), BIOS Fund I QP, LP (Fort Worth, TX — pooled investment fund — 2017; $8.39M reported sold to 31 investors), BIOS Vision SPV II, LP (Fort Worth, TX — pooled investment fund — 2015; $956K reported sold to 23 investors), BIOS OMI SPV I, LP (Fort Worth, TX — pooled investment fund — 2016; $840K reported sold to 27 investors) and BIOS Memory SPV II, LP (Fort Worth, TX — pooled investment fund — 2016; $813K reported sold to 21 investors).

What this means A repeat sponsor — 5 separate companies raised money with this person listed as promoter, over about 2 years. Across those companies the filings report $25.4M sold in total.

Listed alongside BIOS Equity Partners (5 shared filings, management entity), Bios Capital Management, LP (5 shared filings, management entity), Cavu Management, LP (5 shared filings, management entity), Glenn Louis BIOS Advisors GP (5 shared filings, management entity), Glenn Louis CAVU Advisors (5 shared filings, management entity) and 4 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around BIOS. Each name links to their own page.

All 5 issuers belong to the sponsor group Bios (35 issuers, $212.4M reported sold, 2013–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Bios has 35 companies on file and $212.4M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 5 public filings for BIOS Research and found 4 differences: Form D filed 33 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for BIOS Research has not run yet — it is joining a line of 6,682 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:15 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched BIOS Research..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:15 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

4 differences found between the filings for BIOS Research (compared 5 filings on Oct 24, 2026)

Note · Feb 25, 2016 – Mar 29, 2016

Form D filed 33 days after the first sale — BIOS Memory SPV II, LP

The filing says the first sale was Feb 25, 2016. The Form D was filed Mar 29, 2016 — 33 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 18 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Nov 28, 2016 – Dec 9, 2016

No amendment in the last 12 months on an offering that may still be open — BIOS OMI SPV I, LP (latest filing Dec 9, 2016)

The latest filing for this offering is dated Dec 9, 2016 (first sale Nov 28, 2016). It reports $840,000 sold of $1,545,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Feb 25, 2016 – Mar 29, 2016

No amendment in the last 12 months on an offering that may still be open — BIOS Memory SPV II, LP (latest filing Mar 29, 2016)

The latest filing for this offering is dated Mar 29, 2016 (first sale Feb 25, 2016). It reports $812,784 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Aug 3, 2015 – Aug 12, 2015

No amendment in the last 12 months on an offering that may still be open — BIOS Vision SPV II, LP (latest filing Aug 12, 2015)

The latest filing for this offering is dated Aug 12, 2015 (first sale Aug 3, 2015). It reports $955,843 sold of $1,449,071 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 5 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 24, 2017 D
BIOS Fund I, LP
File 021-283299
$0$0$0 (est.)
Investment Managers will receive origination fee. General Partner will receive performance allocation and management fee. Origination fee, performance allocation and management fee are described in the confidential offering materials.
None listed on this filingEDGAR ↗
Mar 24, 2017 D
BIOS Fund I QP, LP
File 021-283297
$0$0$0 (est.)
Investment Managers will receive origination fee. General Partner will receive performance allocation and management fee. Origination fee, performance allocation and management fee are described in the confidential offering materials.
None listed on this filingEDGAR ↗
Dec 9, 2016 D
BIOS OMI SPV I, LP
File 021-276029
$0$0$0 (est.)
The Investment Managers will receive an origination fee for each capital contribution the Issuer receives. Also, the General Partner is entitled to receive performance allocations. Both are described in the Issuer's confidential offering materials.
None listed on this filingEDGAR ↗
Mar 29, 2016 D
BIOS Memory SPV II, LP
File 021-260143
$0$0$0 (est.)
The Investment Managers will receive an origination fee for each capital contribution. The General Partner will receive a performance allocation. The origination fee and the performance allocation are described in the confidential offering materials.
None listed on this filingEDGAR ↗
Aug 12, 2015 D
BIOS Vision SPV II, LP
File 021-245590
$0$0$0 (est.)
The Investment Managers are entitled to receive an origination fee for each capital contribution and the GPs are entitled to receive performance allocations, which fees and allocations are fully described in the Issuer's confidential offering materials.
None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this entity is listed on (latest filing per offering, per issuer).

Deals 5

Every issuer that named BIOS Research on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pooled Investment Fund · group: Bios

BIOS Fund I, LP

Fort Worth, TX · Mar 24, 2017
  • Mar 24, 2017 · D · $14,430,412 sold of $14,430,412 · 87 investors · min. $5,000 · role: Promoter (Investment Manager) EDGAR ↗

Raised $14.4M from 87 investors (100% of the $14.4M target) as of the latest filing. Bios is listed as promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bios

BIOS Fund I QP, LP

Fort Worth, TX · Mar 24, 2017
  • Mar 24, 2017 · D · $8,390,945 sold of $8,390,945 · 31 investors · min. $20,000 · role: Promoter (Investment Manager) EDGAR ↗

Raised $8.39M from 31 investors (100% of the $8.39M target) as of the latest filing. Bios is listed as promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bios

BIOS OMI SPV I, LP

Fort Worth, TX · Dec 9, 2016
  • Dec 9, 2016 · D · $840,000 sold of $1,545,000 · 27 investors · min. $5,000 · role: Promoter (Investment Manager) EDGAR ↗

Raised $840K from 27 investors (54% of the $1.54M target) as of the latest filing. Bios is listed as promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bios

BIOS Memory SPV II, LP

Fort Worth, TX · Mar 29, 2016
  • Mar 29, 2016 · D · $812,784 sold of $1,000,000 · 21 investors · min. $3,414 · role: Promoter (Investment Manager) EDGAR ↗

Raised $813K from 21 investors (81% of the $1M target) as of the latest filing. Bios is listed as promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Bios

BIOS Vision SPV II, LP

Fort Worth, TX · Aug 12, 2015
  • Aug 12, 2015 · D · $955,843 sold of $1,449,071 · 23 investors · min. No minimum reported · role: Promoter (Investment Manager) EDGAR ↗

Raised $956K from 23 investors (66% of the $1.45M target) as of the latest filing. Bios is listed as promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Bios 9

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity

Steelhead Capital Management,

Promoter · 5 shared filings (5 issuers) · also on 18 other issuers

Steelhead Capital Management, is on 23 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

Cavu Management, LP

Promoter · 5 shared filings (5 issuers) · also on 19 other issuers

Cavu Management, LP is on 24 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

Bios Capital Management, LP

Promoter · 5 shared filings (5 issuers) · also on 22 other issuers

Bios Capital Management, LP is on 27 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

Glenn Louis CAVU Advisors

Promoter · 5 shared filings (5 issuers) · also on 16 other issuers

Glenn Louis CAVU Advisors is on 21 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

Glenn Louis BIOS Advisors GP

Promoter · 5 shared filings (5 issuers) · also on 15 other issuers

Glenn Louis BIOS Advisors GP is on 20 issuers in total — a repeat sponsor. Their page lists every one.

Management entity

BIOS Equity Partners

Director · 5 shared filings (5 issuers) · also on 1 other issuer

BIOS Equity Partners is on 6 issuers in total — a repeat sponsor. Their page lists every one.

LK
No photo found yet (own website and image search run after this page is viewed)
Person

Leslie Wayne Kreis, Jr.

Executive Officer, Promoter · 5 shared filings (5 issuers) · also on 22 other issuers

Leslie Wayne Kreis, Jr. is on 27 issuers in total — a repeat sponsor. Their page lists every one.

AF
No photo found yet (own website and image search run after this page is viewed)
Person

Aaron Glenn Louis Fletcher

Promoter · 3 shared filings (3 issuers) · also on 31 other issuers

Aaron Glenn Louis Fletcher is on 34 issuers in total — a repeat sponsor. Their page lists every one.

FA
No photo found yet (own website and image search run after this page is viewed)
Person

Fletcher Glenn Louis Aaron

Executive Officer, Promoter · 2 shared filings (2 issuers)

Listed on the same filings as BIOS Research. Their page shows their other deals.

The team behind the deals

Sponsor group

Bios

35 issuers · 71 filings · $212.4M reported sold · 2013–2026

One team, 35 deal companies. BIOS Research is listed on 5 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name BIOS Research.

Same business address

14 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched BIOS Research.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

BIOS Research is matched through the issuers it is listed on; property records are tied to issuers, not to management companies, on this site. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 5 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers BIOS Research is listed on: none on file. No website or social profile named in BIOS Fund I, LP's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #274,782 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Fort Worth, TX). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this entity

Members get an email when BIOS Research appears on a new Form D, or when a court case or SEC action is matched to them. See plans →